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HCN channels are highly expressed and functionally relevant in neurons and increasing
evidence demonstrates their involvement in the etiology of human epilepsies. Among
HCN isoforms, HCN4 is important in cardiac tissue, where it underlies pacemaker
activity. Despite being expressed also in deep structures of the brain, mutations of this
channel functionally shown to be associated with epilepsy have not been reported yet.
Using Next Generation Sequencing for the screening of patients with idiopathic epilepsy,
we identified the p.Arg550Cys (c.1648C>T) heterozygous mutation on HCN4 in two
brothers affected by benign myoclonic epilepsy of infancy. Functional characterization in
heterologous expression system and in neurons showed that the mutation determines a
loss of function of HCN4 contribution to activity and an increase of neuronal discharge,
potentially predisposing to epilepsy. Expressed in cardiomyocytes, mutant channels
activate at slightly more negative voltages than wild-type (WT), in accordance with
borderline bradycardia. While HCN4 variants have been frequently associated with
cardiac arrhythmias, these data represent the first experimental evidence that functional
alteration of HCN4 can also be involved in human epilepsy through a loss-of-function
effect and associated increased neuronal excitability. Since HCN4 appears to be highly
expressed in deep brain structures only early during development, our data provide
a potential explanation for a link between dysfunctional HCN4 and infantile epilepsy.
These findings suggest that it may be useful to include HCN4 screening to extend the
knowledge of the genetic causes of infantile epilepsies, potentially paving the way for the
identification of innovative therapeutic strategies.
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INTRODUCTION
The genetic causes of epilepsy are unknown in the vast majority
of patients, although the disease often affects more than one
member of the family, suggesting a genetically based disease.
Studies investigating the etiology of generalized epilepsies often
reveal complex and multifactorial inheritance features (Helbig
et al., 2008). A recent genome-wide study, for example, has
reported broad locus heterogeneity in generalized epilepsies
(Epi4K Consortium and Epilepsy Phenome/Genome Project,
2017).
Nevertheless, a small number of causative genetic alterations
have indeed been identified in patients. The most frequent
mutations proposed to be involved in generalized epilepsy have
been observed in the SLC2A1 gene, responsible for the Glucose
transporter type 1-deficiency syndrome and account up to
0.5%–1% of patients (Arsov et al., 2012; Striano et al., 2012).
Other genetic causes involve the dysfunction of ion channels,
mainly Na+ and K+ (Thomas and Berkovic, 2014).
Several studies have shown that HCN channels are potentially
involved in the pathogenesis of epilepsy (Tang et al., 2008;
Baruscotti et al., 2010; Dibbens et al., 2010; DiFrancesco
and DiFrancesco, 2015). Among the four different isoforms
known (HCN1–4), each with different kinetic and voltage
characteristics, isoforms 1, 2 and 4 are widely expressed in
neurons, with a diverse distribution in brain areas. The role
of HCN channels in neurons of the brain has been only
partially clarified, but it is established that they contribute to
the control of neuronal discharge and their dysfunction can
lead to hyperexcitability and uncontrolled action potential firing,
thus predisposing to seizures (Robinson and Siegelbaum, 2003;
Biel et al., 2009; Benarroch, 2013; DiFrancesco and DiFrancesco,
2015).
Animal models lacking specific isoforms of the channel
have shown different phenotypes. HCN1 knockout leads to
a significant increase of neuronal firing and hyperexcitability,
without however causing spontaneous seizures (Huang et al.,
2009; Santoro et al., 2010). HCN2 loss-of-function instead
causes spontaneous generalized epilepsy, both in genetically
modified animals (Ludwig et al., 2003) and in animals carrying
a spontaneous truncating mutation (Chung et al., 2009).
In human patients, the evidence for HCN mutations
promoting epilepsy is rapidly growing. So far, mutations
in HCN2 have been found and characterized in patients
with idiopathic generalized epilepsy (IGE; Tang et al., 2008;
DiFrancesco et al., 2011), febrile seizures and genetic epilepsy
with febrile seizures plus (Dibbens et al., 2010; Nakamura et al.,
2013) and GGE (Li et al., 2018). Mutations in HCN1 have been
described in infants affected by a severe form of progressive
epileptic encephalopathy, with difficult control of seizures and
poor prognosis (Nava et al., 2014) and very recently in a patient
with GGE (Bonzanni et al., 2018).
HCN4 channels mediate pacemaker activity in the heart
(Brown et al., 1979) and many mutations associated with cardiac
arrhythmias have been characterized (Schulze-Bahr et al., 2003;
Milanesi et al., 2006; Baruscotti et al., 2010; DiFrancesco, 2013,
2015).
Experimental data show that HCN4 is also highly expressed in
the central nervous system (CNS), mainly in deep structures such
as thalamic nuclei (Bender et al., 2001), hippocampus and spinal
cord (Seo et al., 2015). The brain areas expressingHCN4 channels
are critical for the development of seizures, and genetic alteration
of these channels is potentially epileptogenic.
A recent report has indicated the presence of HCN4 loss-
of-function mutations in generalized epilepsy patients (Becker
et al., 2017). However, HCN4 variants were found in only a
single affected individual, and changes of excitability following
expression in neurons were not investigated.
Since HCN4 is highly expressed in cortical regions (including
the hippocampus) specifically during infancy, and its expression
rapidly declines with age (Brewster et al., 2007; Kanyshkova et al.,
2009; Battefeld et al., 2012; Seo et al., 2015), HCN4 deficit may
represent a potential mechanism for infantile forms of epilepsy.
Here, we report the identification of a mutation of HCN4 in
two brothers affected by myoclonic epilepsy of infancy. By means
of functional studies involving transfection of wild-type (WT)
and mutant channels first into CHO cells and then into neurons,
we show that this mutation determines a loss-of-function effect
and, for the first time with HCN4 mutations, an increased
neuronal excitability potentially contributing to the development
of infantile epilepsy.
MATERIALS AND METHODS
Patient Recruitment and Data Collection
We recruited patients with diagnosis of idiopathic generalized
and partial epilepsy according to definition (Commission on
Classification and Terminology of the International League
Against Epilepsy, 1989). For all patients included, we collected
information about gender, type of epilepsy (generalized,
partial or undetermined) and inheritance of the disease,
considered as sporadic (the patient is the only affected
of the family) or familiar (at least one member of the
proband’s family is affected by epilepsy with similar features).
In order to identify a possible symptomatic etiology of
seizures, clinical and instrumental data of patients with
epilepsy were analyzed in detail. Structural causes, such as
cerebrovascular disease, tumor or trauma, were investigated with
1 or 1.5 T brain MRI with proper sequences (T1, T1 with
Gadolinium, T2/FLAIR, Inversion Recovery); biochemical and
hematological tests were performed to exclude metabolic
causes. Other seizure-provoking factors like antipsychotic or
antidepressant therapy, alcohol or drug dependency, infection
of the CNS were excluded. EEG was used to characterize
features of epilepsy. Subjects with symptomatic epilepsy were
excluded from recruitment. This study was carried out in
accordance with the recommendations of the Italian Ministry
of Health. The protocol was approved by the local Institutional
Review Board of the Besta Institute and S. Gerardo Hospital
(protocol number 1459). All subjects gave written informed
consent in accordance with the Declaration of Helsinki. Upon
acceptance of the informed consent, patients underwent a
small blood withdrawal in EDTA anticoagulant for DNA
extraction.
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TABLE 1 | List of genes analyzed in the customized panel.
DNA-binding
protein
ARX, CHD2, EMX2, FOXG1, HESX1, MBD5, MECP2, MEF2C,
TCF4, ZEB2
Enzyme AFG3L2, ALDH7A1, CDKL5, CERS1, CSTB, CTSD, EMPM2A,
GBA, KDM6A, KMT2D, MAGI2, NEU1, NHLRC1, PAFAHB1B,
SMS, TPP1, EBE3A, WWOX
Ion channels
and receptors
ATP1A2, CACNA1A, CHRNA2, CHRNB2, CLCN2, GABRB3,
GABRG2, GRIN2B, HCN1, HCN2, HCN4, KCNC1, KCNE2,




ADGRG1, APBA2, CAV3, COL4A1, COL4A2, DCX, FLNA,
GRASP, PCDH19, SLC2A1, SLC6A8, SLC9A6, TUBA1A,
TUBB2B, TUBB3, TUBB8
Other ARHGEF9, C10ORF2, CLN6, DEPDC5, GOSR2, NPC1,
NPC2, PEX5L, SCARB2, SRPX2, STX1B, SYNGAP1,
TBC1D24, VLDLR
DNA Extraction and Genetic Screening
Genomic DNA was prepared from peripheral-blood
lymphocytes using standard procedures, as previously reported
(DiFrancesco et al., 2014, 2015).
We used a TruSeq Custom Amplicon (Illumina), with
a Studio Design software (Illumina Inc., San Diego, CA,
USA) to customize a gene panel for the analysis of the
genes coding for HCN ion channels and accessory proteins:
HCN1 (NM_021072; NP_066550), HCN2 (NM_001194;
NP_001185), HCN4 (NM_005477; NP_005468), APBA2
(NM_005503; NP_005494), CAV3 (NM_033337; NP_203123),
MAGI2 (NM_012301; NP_036433), FLNA (NM_001110556;
NP_001104026), KCNE2 (NM_172201; NP_751951), PEX5L
(NM_016559; NP_057643), GRASP (NM_181711; NP_859062).
Following the identification of the variant p.Arg550Cys
(c.1648C>T) on HCN4, the DNA of both probands was
analyzed with a more extended Next-Generation Sequencing
(NGS) panel. This analysis was conducted in order to rule out
any other possible causative genetic factor associated with the
disease. We used a Nextera Rapid Capture method with Studio
Design software (Illumina Inc., San Diego, CA, USA) using a
customizing gene panel (see Table 1). The mean of coverage
for this panel was 96%; the coverage of each gene is available
on request. Obtained sequences were aligned to the reference
genome (GRCh37/hg19) usingMiSeq software. Data analysis was
obtained using the following software: Illumina MiSeq Reporter
vs. 2.4.60, Illumina Variant Studio vs. 2.2, Qiagen CLCGenomics
Workbench vs. 7.0.
Variants with MAF >1% reported in the dbSNP1,
1000 Genome2, EVS database3, ExAC database4 and gnomAD
browser5 were considered benign variants and excluded from
the report.
Cell Culture
CHO cells (ATCC, cat# CCL-61, RRID:CVCL_0214) were






Scientific) supplemented with 10% fetal bovine serum (FBS,
Thermo Fisher Scientific), 1.5 g/L sodium bicarbonate, 2 mM
L-glutamine, 100 U/ml penicillin and 100 g/ml streptomycin
(Sigma-Aldrich).
Neonatal rat cortical neurons (NRCNs) were isolated as
previously described (DiFrancesco et al., 2011). Sprague-Dowley
rat pups from post-natal day 3 (Envigo, RRID:RGD_5508397)
were euthanized by cervical dislocation, in accordance with
the Italian and UE laws (D. Lgs n◦ 2014/26, 2010/63/UE) and
following the approval of the Ethical Committee of the University
of Milano and of the Italian Ministry of Health (protocol no.
1197/2015). Briefly, brains were removed and placed on ice
in dissociation medium (in mmol/L: 134 Na-isethionic acid,
23 glucose, 15 HEPES, 10 kynurenic acid, 2 KCl, 4 MgCl2,
0.1 CaCl2, pH 7.2). The cerebral cortex was dissected from each
brain hemisphere, minced with fine tweezers and digested in
dissociation medium supplemented with 9.7 U/mL type XIV
protease (Sigma-Aldrich) for 20 min at 37◦C. Neurons were
subsequently isolated mechanically using fire-polished Pasteur
pipettes. 1 × 106 cells were plated onto 35-mm poly-D-
lysine-coated dishes in a mixture of dissociation medium and
neurobasal medium, containing Neurobasal-A medium with
1× B27 supplement, 1 mM GlutaMAX I, 10 ng/mL human
bFGF (all from Thermo Fisher Scientific), 50 U/ml penicillin and
50 g/ml streptomycin (Sigma-Aldrich), and let to adhere for 1 h
at 37◦C and 5% CO2. The medium was then replaced with fresh
neurobasal medium and neurons were kept at 37◦C and 5% CO2
until transfection.
Neurons selected for electrophysiological analysis were
pyramidal neurons based on their morphology. Neurons with
depolarized resting potential (more positive than −30 mV) or
low input resistance (lower than 200 M) were discarded.
Neonatal rat cardiomyocytes (NRVCs) were isolated from
the same 3-day-old rats (Envigo), as previously reported
(Avitabile et al., 2011). After heart removal, ventricles were
chopped with fine tweezers in PBS and enzymatically digested
by repeated digestions of 15 min at 37◦C with collagenase
I (136.8 U/ml, Whorthington) and pancreatine (0.6 mg/ml,
Sigma-Aldrich) added to ADS solution (in mmol/L: 116.4 NaCl,
5.4 KCl, 1 NaH2PO4·H2O, 0.8 MgSO4·H2O, 5.5 glucose,
20 HEPES, pH 7.4). Cardiomyocytes were then plated onto
35-mm dishes and maintained in DMEM/M199 (Sigma-
Aldrich), supplemented with 10% Horse Serum (Euroclone),
5% FBS (Thermo Fisher Scientific), L-glutamine 2 mmol/L
and 1% Pen-Strep (Sigma-Aldrich) at 37◦C and 5% CO2 until
transfection.
Plasmids and Transfection
The WT human (h) HCN4 cDNA sequence was cloned
in pcDNA1.1 vector. Site-directed mutagenesis (QuikChange
II Site-Directed Mutagenesis Kit, Agilent Technologies) was
performed to introduce the R550C mutation using the
following primers: F 5′-cgcccgacacccggcagtgcatccacgactactac-3′,
R 5′-gtagtagtcgtggatgcactgccgggtgtcgggcg-3′. Automated DNA
sequence analysis (BioFab Research, Italy) verified the mutation.
CHO cells plated on 35-mm dishes were transfected with
1.5 µg of either WT or R550C hHCN4 or with 0.75 µg of
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both using Fugene HD (Promega). The transfection of the same
amount of WT and R550C constructs was used to mimic the
heterozygous condition of the patients. Co-transfection of 0.3 µg
pmaxGFP (Lonza) was used to select transfected cells for patch
clamp experiments. Cortical neurons and ventricular myocytes
were transfected the day after isolation using Lipofectamine 2000
(Thermo Fisher Scientific) following manufacturer instructions.
For neuron transfection, we used 0.25 µg of WT or R550C
hHCN4, or 0.12 µg of both, and 0.1 µg of pmaxGFP. For
cardiomyocyte transfection, 1.2 µg of WT or R550C hHCN4, or
0.6 µg of both, and 0.3 µg of pmaxGFP were used.
Electrophysiology
Electrophysiological analysis was performed 48 h after
transfection using the patch-clamp technique in whole-cell
configuration. CHO cells and NRVCs were dissociated with
trypsin-EDTA (Sigma-Aldrich) and plated at low density
on 35-mm dishes, in order to record hHCN4 current from
single cells. Ventricular myocytes were kept at 36 ± 1◦C
while CHO cells and cortical neurons were kept at room
temperature. CHO cells and NRVCs were kept in Tyrode
solution containing (in mmol/L): 140 NaCl, 5.4 KCl,
1.8 CaCl2, 1 MgCl2, 5.5 D-glucose, 5 Hepes-NaOH; pH 7.4.
NRCNs were kept in a physiological extracellular solution
containing (in mmol/L): 129 NaCl, 35 glucose, 10 Hepes, 3 KCl,
1.8 MgSO4, 1.6 CaCl2, 1.25 NaH2PO4; pH 7.4. In CHO cells,
the hHCN4 current was recorded using a high-K solution
containing (in mmol/L): 110 NaCl, 30 KCl, 5 Hepes-NaOH,
1.8 CaCl2, 0.5 MgCl2, 1 BaCl2, 2 MnCl2, pH 7.4. In NRVCs, the
hHCN4 current was dissected by adding 1 BaCl2, 2 MnCl2 to
Tyrode solution.
For recordings in CHO cells and NRVCs, patch-clamp
pipettes had a resistance of 4–7 M when filled with the
intracellular-like solution containing (in mmol/L): 130 KCl,
10 NaCl, 5 EGTA-KOH, 0.5 MgCl2, 2 ATP (Na-salt), 5 creatine
phosphate, 0.1 GTP, 10 Hepes-KOH; pH 7.2. For recordings
in NRCNs, pipettes had a resistance of 7–10 M and
were filled with an intracellular-like solution containing (in
mmol/L): 120 K-gluconate, 20 P-creatine, 15 KCl, 10 Hepes,
2 MgCl2, 2 ATP, 0.2 GTP, 0.2 EGTA, 0.1 leupeptin;
pH 7.2.
hHCN4 currents were recorded from GFP-expressing cells in
voltage-clampmode, applying voltage steps in 20 mV increments
to the range −35/−135 mV or to the range −35/−125 mV,
followed by a fully-activating step to −135 mV or −125 mV
for CHO cells and cardiac myocytes, respectively. In cortical
neurons, hHCN4 current was activated by hyperpolarizing steps
in 20 mV increments to the range −35/−115 mV. At each
voltage, steps were long enough to reach steady state of current
activation. The holding potential (hp) was set to −30 mV
in all experiments. Activation curves were obtained from tail
currents (for CHO cells and cardiomyocytes) or by calculating
the conductance at each voltage step and normalizing it to
maximum conductance (for cortical neurons) and were fitted to
the Boltzmann equation:
y = 1/ (1+ exp ((V − V1/2) /s))
where V is voltage, y the fractional activation, V1/2 the
half-activation voltage, and s the inverse-slope factor.
hHCN4 current density was obtained from current amplitude at
each potential normalized to cell capacitance. Cell capacitance
was calculated by integrating capacitive currents elicited by a
10-mV voltage step from −35 mV to −45 mV. Time constants
were obtained by fitting activation and deactivation current
traces with a single exponential function. Action potential firing
of cortical neurons was recorded in current-clamp mode by
holding membrane potential at −70 mV for 3 s and applying
depolarizing current steps in 10 pA increments.
Experimental Design and Statistical
Analysis
Data were analyzed with Clampfit (Axon) and Origin Pro 9
(Origin Lab). Activation curves were compared by analyzing the
V1/2 using one-way ANOVA followed by Fisher’s LSD post hoc
test; significance level was set to p = 0.05. Data outliers were
excluded using Tukey’s method. Data were collected from at least
three different transfection experiments or primary cultures.
RESULTS
Identification of the HCN4 p.Arg550Cys
Variant in Familiar Epilepsy
For the present study, we recruited 88 patients affected by
idiopathic epilepsy, which was classified as generalized, partial
or undetermined (see Table 2 for details). The disease had
properties compatible with familial inheritance in 38 cases and
was apparently sporadic in 50.
The genetic screening of patients with TruSeq technology
identified the HCN4 variant p.Arg550Cys (c.1648C>T,
rs150691273) in two brothers (Figure 1A). The residue Arg550 is
located in the B’ helix of the C-linker (Figure 1C, top), as also
visible in the 3D structure of the C-terminus (Figure 1D, right)
reconstructed from X-ray data (Xu et al., 2010). A positively
charged amino acid is highly conserved among different species
(Figure 1C, bottom), suggesting a significant functional role.
The p.Arg550Cys mutation determines a charge variation,
from the positively charged residue arginine to the polar
amino acid cysteine. Biophysical studies have shown that the
homologous residue in mHCN2 channels (K472) links through
salt bridges with two other residues (E502 and D542), forming
inter- and intra-subunit interactions which help stabilize the
tetrameric arrangement of the C-terminal domain and can, when
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disrupted, modify channel kinetics (Craven and Zagotta, 2004).
The expanded view of Figure 1D (left) shows the positions
of the homologous hHCN4 residues (R550, E580 and D620).
Interatomic distances are similar to those found in mHCN2
(data not shown), suggesting that salt bridges are functionally
important also in human HCN4 channels.
We extended the genetic screening within the family of the
two probands and found that this variant had been inherited
by their father, for whom we lack anamnestic data relative to
his youth. We can therefore neither exclude nor confirm the
presence of infantile seizures in this subject. In order to rule out
any further genetic abnormalities putatively responsible for the
medical case history, both probands underwent additional NGS
analysis using a Nextera approach, aimed to screen a large set of
genes known to be involved in the pathogenesis of epilepsy (see
Table 1 for a complete list). This additional panel did not identify
any other genetic variants of potential interest.
Case Description
The two brothers investigated here were born from a
physiological pregnancy, by non-consanguineous parents.
Their phenotype and the evolution of their clinical histories are
similar in many ways. They both presented the first seizures
before the first year of age, characterized by loss of consciousness
and myoclonus of the four limbs, with occasional drop to
the ground. Medical history was negative for febrile seizures,
traumatic brain injury or infections. EEG analysis showed
normal background, with generalized epileptiform activity
prevalent in the anterior regions, associated with myoclonus
induced by acoustic stimulus, with negative intermittent
photic stimulation (Figure 1B, patient 3). Neuroradiological
examinations were negative. Based on clinical and EEG findings,
they were diagnosed with benign myoclonic epilepsy of infancy
and treatment with valproate was started with full remission of
seizures, which terminated at around 2 12 years of age for both
brothers. Anti-epileptic treatment was interrupted when the
brothers were 4 years of age, without reporting any additional
seizures. Both patients showed a modest delay in language
development, recovered by logopedics. In patient 3 only,
follow-up EEG remained positive for interictal epileptic activity
until the age of 12. For patient 4 a formal cognitive assessment
showed a subclinical mental disability (IQ 76).
The R550C Mutation Causes a Negative
Shift of the HCN4 Channel Activation Curve
To verify if the R550C mutation modifies functional properties
of HCN4 channels, we transfected CHO cells with WT,
homozygous mutant (R550C) or heterozygous WT/mutant
(WT/R550C) HCN4 channels and performed patch-clamp
analysis.
Representative traces of HCN4 currents recorded from
CHO cells expressing the three different channels, and plots
of the mean activation curves thus obtained, are shown in
Figures 2A,B.
The voltage dependence of activation of both homozygous
mutant and heterozygous WT/mutant channels was shifted by
about 4–5 mV towards more negative voltages relative to WT
channels.
Statistical comparison of the activation curves showed that
both R550C and WT/R550C curves were significantly different
from the WT curve (F(2,79) = 4.917, p = 0.010). V1/2 values of
R550C and WT/R550C were similar (t = −0.24, p = 0.811) and
significantly different from WT (t = −2.65, p = 0.009; t = −2.63,
p = 0.010 for R550C and WT/R550C, respectively).
On the other hand, current densities did not change
significantly (Figure 2C; F(2,60) = 0.290, p = 0.750, one-way
ANOVA at −135 mV) nor did time constants of activation and
deactivation (Figure 2D), with the exception of the deactivation
time constant at−35 mV (F(2,23) = 7.519, p = 0.003).
We also verified if the R550C mutation had any effect on
the cAMP-induced channel activation (DiFrancesco and Tortora,
1991) by comparing currents recorded in the presence and in the
absence of cAMP in the recording pipette.
The left panels of Figure 3 show sample current traces
recorded from cells expressing either WT (top) or R550C
mutant channels (bottom) during a two-step voltage clamp to
−75/−125 mV (mid/full activation range).
In both cases, traces recorded in the presence of 10 µm cAMP
in the whole-cell pipette showed, after normalization to maximal
current, an increase at −75 mV and a decrease at −125 mV,
indicating a shift of the activation curve to more positive voltages
in the presence of cAMP. In the right panels, a more complete
analysis shows that the mean activation curves ofWT and R550C
channels, as fitted to the Boltzmann equation, cause statistically
significant V1/2 shifts of 7.5 and 7.2 mV, respectively (cAMP vs.
control: WT, F(2,178) = 27.83, p< 0.0001; R550C, F(2,150) = 33.32,
p < 0.0001) These data indicate that the R550C mutation does
not modify the cAMP-dependence of channel activation.
The HCN4 R550C Mutation Increases
Neuronal Excitability by a
Loss-of-Function Effect
In order to evaluate if HCN4 channels carrying the R550C
mutation are able to modify neuronal excitability, we transfected
NRCNs with either WT, R550C or WT/R550C HCN4 channels,
and recorded currents in patch-clamp experiments
(Figure 4).
As expected from the properties of HCN channels,
transfection of all channel types resulted in a depolarization of
the resting membrane potential and a strong decrease of input
resistance when comparing with untransfected channels (see
Table 3).
Expression in neurons revealed mutant channel properties
similar to those observed in CHO-transfected cells. The V1/2 of
activation curves of both homozygous R550C and heterozygous
WT/R550C channels were similar (t = 1.725, p = 0.091) and
shifted to more negative voltages by 7.7 (R550C) and 4.7 mV
(WT/R550C) relative to the WT activation curve (t = −5.13,
p = 5.03e-6; t =−2.78, p = 0.007, respectively).
Also as in CHO cells, the R550Cmutation did not affect mean
current densities (Figure 4C; F(2,55) = 0.04, p = 0.96, one-way
ANOVA at −135 mV). We also did not find significant changes
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FIGURE 1 | Mutation R550C found in the HCN4 C-linker region of epileptic siblings. (A) Family pedigree. Dotted symbols represent individuals carrying the
HCN4 R550C mutation in heterozygosis (probands and their father); red symbols indicate reported diagnosis of benign myoclonic epilepsy of infancy. (B) EEG of
patient 3 showing normal background, with generalized epileptiform activity prevalent in the anterior regions. (C, top) Schematic representation of one HCN4 channel
subunit showing the six transmembrane domains (S1–S6) and the intracellular N- and C-termini. The C-terminus includes the C-linker, comprising six α-helices (A′ to
F′), and the cyclic nucleotide-binding domain (CNBD, A to C), as indicated. The approximate position of the mutation R550C in the B’ helix is also shown.
(C, bottom) Sequence alignment of the B’ helix of the four human HCN channel isoforms (hHCN4 NP_005468.1, hHCN1 NP_066550.2, hHCN2 NP_001185.3,
hHCN3 NP_065948.1) and of homologous channel regions in other species. Note that at position hHCN4:R550 a positively charged amino acid (arrow) is conserved
in all species indicated. AC, Anolis carolinensis (XP_008119223.1); MG, Meleagris gallopavo (XP_010715467.1); PA, Panulirus argus (AAQ16311.1); DM, Drosophila
melanogaster (NP_001137667.1); Ciona, Ciona intestinalis (AFB83348.1); SP, Strongylocentrotus purpuratus (NP_999729.1). (D, right) Ribbon 3D representation of
the tetrameric arrangement of hHCN4 C-termini, comprising C-linkers and CNBDs, based on X-ray crystallographic data (Xu et al., 2010; PDB ID: 3OTF).
R550 residues in B’ α-helices are drawn as space-filling plots. (D, left) Expanded and rotated view showing residues R550 (green B’ helix), E580 (yellow D’ helix) and
D620 (green β-roll), which may act as salt-bridges (Craven and Zagotta, 2004).
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FIGURE 2 | The R550C mutation causes a shift of the activation voltage-dependence of HCN4 expressed in CHO cells. (A) Representative hHCN4 current traces
recorded during a two-step activation protocol (test range −35/−135 mV, holding potential (hp) = −30 mV) in CHO cells transfected with either wild-type (WT),
R550C or WT/R550C hHCN4, as indicated. (B) Plot of the mean activation curves of hHCN4 currents (WT, filled circles; R550C, open circles; WT/R550C, open
squares). Mutated channels had a slightly, but statistically significant, more negative range of activation than WT channels. V1/2 and s values from Boltzmann curve
fitting were (mV): WT, −74.9 ± 1.0, 8.52 ± 0.38 (n = 33); R550C, −79.1 ± 1.0, 9.41 ± 0.47 (n = 29); WT/R550C, −79.5 ± 1.7, 8.50 ± 0.42 (n = 20). (C) I/V density
curves. Current densities at −135 mV were (pA/pF): WT, −18.3 ± 2.2 (n = 24); R550C, −16.6 ± 2.7 (n = 22); WT/R550C, −15.6 ± 2.8 (n = 17). (D) Mean time
constants of activation (negative to −75 mV) and deactivation (positive to −65 mV). In (C,D) no significant differences were found among the three channel types,
except deactivation time constant at −65. Meaning of symbols as in (A,B).
in the voltage dependence of the time constants of activation
(Figure 4D).
The negative shift of the activation curve indicates a loss
of function of the channel. Since HCN channels are open at
physiological resting membrane potentials of neurons (Pape,
1996; Doan and Kunze, 1999; Lupica et al., 2001; Meuth et al.,
2006; Nolan et al., 2007; Biel et al., 2009), a loss of function and
the consequent, reduced HCN4 current contribution may affect
input membrane resistance as well as restingmembrane potential
(Dyhrfjeld-Johnsen et al., 2009) and thus impact cell excitability.
Indeed, in agreement with the evidence of a loss of function,
transfection of mutant channels led to a significant increase of
neuronal input resistance relative to WT channels, as shown in
Table 3.
In order to address this issue, we sought to compare
membrane excitability of neurons transfected with either WT,
R550C or WT/R500C HCN4. We injected depolarizing current
steps of progressively larger amplitude in neurons (previously
stabilized to a resting potential of −70 mV) and recorded by
patch-clamp their electrical activity.
Representative traces in Figure 5A show that a current step
of 20 pA was sufficient to elicit firing in one untransfected
neuron (top panels), while in another neuron expressing
WT channels (second row of panels labeled ‘‘WT’’), cell
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FIGURE 3 | The R550C mutation does not affect the cAMP dependence of HCN4 channels. Representative current traces recorded during steps to −75/−125 mV
from a hp of −35 mV (left) and mean activation curves (right) in CHO cells expressing WT (top) or R550C mutated channels (bottom). Records and activation curves
labeled “cAMP” were obtained with patch pipettes filled with the standard intracellular-like solution to which 10 µm cAMP was added. Sample traces on the left are
normalized to maximal amplitude at −125 mV. cAMP shifted the hHCN4 channel activation curve by 7.5 and 7.2 mV in WT and R550C-expressing cells, respectively.
V1/2 and s values from Boltzmann fitting were (mV): WT, −76.7 ± 1.4, 9.41 ± 0.49 (n = 16); WT+cAMP, −69.2 ± 1.2, 8.80 ± 0.78 (n = 16); R550C, −80.1 ± 1.6,
8.72 ± 0.59 (n = 14); R550C+cAMP, −72.9 ± 1.1, 9.02 ± 0.51 (n = 13).
excitability was much lower and firing of only a few action
potentials could only be evoked by the largest current
injections applied (100–120 pA). These data confirm similar
findings previously obtained with HCN2 channels (DiFrancesco
et al., 2011) indicating that transfection of the WT isoform
strongly reduces native neuronal firing and represent further
evidence for a functional role of HCN channels in modulating
excitability.
On the other hand, when neurons were transfected with
R550C or WT/R550C mutant HCN4 channels (third and fourth
rows in Figure 5A), a higher level of cell excitability was observed,
and firing of action potential trains could be elicited with current
steps of 80 pA and less.
As shown in the more complete analysis of Figure 5B,
expression of HCN channels clearly led to a large increase
of the firing threshold relative to untransfected neurons
(F(2,87) = 10.149 p = 8.77∗10−6; untr. vs. WT t = −5.28,
p = 9.556∗10−7; untr. vs. R550C t = −3.85, p = 2.25∗10−4;
untr. vs. WT/R550C t = −2.96, p = 0.004). Furthermore,
expression of mutant channels caused neurons to fire on average
at a significantly lower current threshold than WT-expressing
neurons (WT vs. R550C: t =−2.336, p = 0.022;WT vs.WT/R550:
t = −3.277, p = 0.001; R550C vs. WT/R550C: t = −1.116,
p = 0.250), and the mean firing rate of R550C and WT/R550C-
transfected neurons, as measured in the first 500 ms of current
injection, was higher compared to WT-transfected neurons
(Figure 5C).
The R550C Mutation Alters the Properties
of HCN4 Channels Expressed in Neonatal
Rat Ventricular Cardiomyocytes
It is well established that HCN4 channels are strongly expressed
in cardiac cells where they contribute essentially to generation
of cardiac pacemaker activity and control of cardiac rate
(DiFrancesco, 1993, 2010a,b; Baruscotti et al., 2010; DiFrancesco
and Noble, 2012; Wahl-Schott et al., 2014). We sought to
investigate whether the modifications induced by the R550C
mutation are also maintained when channels are transfected into
cardiac myocytes.
We transfected either WT, R550C or WT/R550C
HCN4 channels in neonatal rat ventricular cardiomyocytes
and performed patch-clamp experiments to analyze their
biophysical properties. We choose neonatal rat ventricular
myocytes since although they express an endogenous If current
(Avitabile et al., 2011) which is carried mostly by HCN2 channels
(Shi et al., 1999), this is much smaller than and does not interfere
with the transfected HCN4 current.
The modifications induced by the R550C mutation on the
properties of HCN4 expressed in cardiomyocytes were similar to
those observed in CHO cells and in cortical neurons.
Measurement of activation curves with the protocols
illustrated in Figure 6A showed that mutant channels activate
at slightly but significantly more negative voltages than WT
channels (Figure 6B; F(2,54) = 6.419, p = 0.003, one-way ANOVA
at−125 mV).
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FIGURE 4 | The R550C mutation causes a shift of HCN4 activation curve when expressed in rat neonatal cortical neurons. (A) Representative hHCN4 current traces
recorded during a single step protocol (test range −35/−115 mV, hp = −30 mV) in cortical neurons transfected with either WT, R550C or WT/R550C hHCN4, as
indicated. Breaks in the current traces correspond to a 8.5 s duration. (B) Plot of the mean hHCN4 activation curves (meaning of symbols as in Figure 2). Mutant
channels have activation curves shifted by about 5–8 mV in the negative direction relative to WT channels. V1/2 and s values from Boltzmann fitting were (mV): WT,
−71.1 ± 1.1, 8.4 ± 0.3 (n = 21); R550C, −78.8 ± 1.1, 9.2 ± 0.5 (n = 18); WT/R550C, −75.8 ± 1.2, 9.8 ± 0.6 (n = 12). (C) I/V density curves. Current densities at
−115 mV were (pA/pF): WT, −12.3 ± 1.5 (n = 20); R550C, −12.7 ± 1.8 (n = 19); WT/R550C, −13.1 ± 2.2 (n = 19). (D) Mean time constants of activation. In (C,D)
no significant differences were found among the three channel types.
Activation curves of R550C and WT/R550C channels had
V1/2 values not significantly different from each other (t = 1.32,
p = 0.192) but underwent statistically significant shifts of about
6 and 3.7 mV relative to the WT curve (t = −3.47, p = 0.001;
t = −2.36, p = 0.021, respectively). No differences were found
in the current densities of mutant vs. WT channels (Figure 6C;
F(2,45) = 0.12, p = 0.89, one-way ANOVA), nor in the time
constants of activation (Figure 6D).
TABLE 3 | Electrophysiological properties of untransfected and transfected neurons.
Untransfected WT R550C WT/R550C
Resting potential −52.7 ± 3.9 −39.3 ± 1.5∗ −42.2 ± 1.3∗ −42.0 ± 1.1∗
(mV) n = 8 n = 27 n = 32 n = 25
Input resistance at −70 mV 1814.3 ± 230.7 522.5 ± 54.5∗ 744.8 ± 89.6∗§ 910.1 ± 80.7∗§
(M) n = 8 n = 27 n = 32 n = 25
∗p < 0.05 vs. untransfected; §p < 0.05 vs. WT. All tests by one-way ANOVA and Fisher LSD post hoc test.
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FIGURE 5 | Membrane excitability of neonatal rat cortical neurons (NRCNs) increases in cells expressing mutant vs. WT channels. (A) The top three panels show
representative voltage traces recorded upon injection of 10, 20 and 30 pA current steps applied from cells held at −70 mV (dashed lines) in untransfected cortical
neurons. The remaining panels show traces recorded upon injection of 80, 100 and 120 pA current steps in cortical neurons transfected with either WT, R550C or
WT/R550C hHCN4, as indicated. Time and voltage scales apply to all panels. (B) Plot of the current necessary to trigger the first action potential (current threshold)
in untransfected (open diamonds), WT (filled circles), R550C (open circles) and WT/R550C-transfected neurons (open squares). Shown are all recorded data and
mean ± SEM values (in pA: untransfected: 22.5 ± 4.12, n = 8; WT: 86.8 ± 7.5, n = 25; R550C: 68.1 ± 4.9, n = 32; WT/R550C: 58.8 ± 5.6, n = 24;
∗p < 0.05 relative to untransfected; §p < 0.05 relative to WT). (C) Plot of the mean firing rate, measured during the first 500 ms, as a function of the current step
injected in untransfected neurons or neurons transfected with WT, R550C or WT/R550C channels (symbols as in B).
Negative shifts of the activation range of HCN4 channels
caused by specific channel mutations have often been associated
with symptomatic or asymptomatic bradycardia (Schulze-
Bahr et al., 2003; Milanesi et al., 2006; DiFrancesco, 2013).
Although neither patient presented overt cardiac abnormalities,
in childhood or adulthood, we decided to analyze the cardiac
performance of the family members carrying the HCN4 R550C
mutation. Both patients and their father therefore underwent
a detailed cardiac characterization with electrocardiograms
(ECG), 24-h Holter ECG and transthoracic echocardiogram. No
structural abnormalities were found in any of the subjects.
ECGs taken at rest indicated that both probands had rates
of 59 bpm, values which are just below the upper limit of
bradycardic rates. Interestingly, the father (individual 1), also
carrying the heterozygous R550C mutation, had a resting rate
only slightly higher (62 bpm). These observations suggest that
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FIGURE 6 | The R550C mutation causes a negative shift of the HCN4 activation curve when expressed in cardiac myocytes. (A) Representative hHCN4 current
traces recorded during a two-step activation protocol (test range −35/−125 mV, hp = −30 mV, fully activating voltage = −125 mV) in ventricular myocytes
transfected with either WT, R550C or WT/R550C hHCN4, as indicated. (B) Plot of the mean activation curves of hHCN4 currents. Mutated channels have activation
curves shifted by −3.7 to −6 mV relative to WT. V1/2 and s values from Boltzmann fitting were (mV): WT, −72.4 ± 1.2, 7.0 ± 0.4 (n = 21); R550C, −78.4 ± 1.3,
9.7 ± 0.7 (n = 15); WT/R550C, −76.1 ± 1.0, 8.7 ± 0.6 (n = 21). (C) I/V density curves. Current densities at −125 mV were (pA/pF): WT, −33.9 ± 6.7 (n = 19);
R550C, −38.8 ± 9.3 (n = 12); WT/R550C, −33.8 ± 7.2 (n = 17). (D) Mean time constants of activation. In (C,D) no significant differences were found among the
three channel types.
the slight negative shift of the activation curve associated with
the R550C mutation is compatible with the moderately low heart
rates of individuals carrying the mutation.
Taken together our results show that the R550C mutation,
identified in two epileptic brothers with the same epileptic
phenotype, similarly modifies the HCN4 channel biophysical
properties in CHO cells, in neurons and in cardiac myocytes.
In particular, in neurons this mutation produces an
increased membrane excitability, compatible with a potential
predisposition to epilepsy.
DISCUSSION
With the exception of few epileptic syndromes, such as the
Dravet syndrome, the genetic causes of epilepsies are generally
poorly understood. HCN ion channels are now emerging as
potential key players in human epilepsy (Reid et al., 2012; Shah
et al., 2013; DiFrancesco and DiFrancesco, 2015), and HCN
channel mutations have already been identified in patients and
associated with epilepsy (Dibbens et al., 2010; DiFrancesco et al.,
2011; Nakamura et al., 2013; Nava et al., 2014).
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We have identified and characterized an HCN4 variant
(R550C) in two brothers affected by benign myoclonic epilepsy
of infancy. Electrophysiological characterization showed that this
mutation induces a leftward shift in the voltage dependence of
HCN4 activation both in homo and heterozygosis, according
to a dominant effect of the mutation. Compared to WT, fewer
mutated channels are open at rest, leading to reduced Ih
and higher input resistance, changes normally associated with
increasedmembrane excitability (Dyhrfjeld-Johnsen et al., 2009).
Our functional studies indeed show that neurons expressing
mutant channels present lower current thresholds to firing
and higher firing rates. These alterations are consistent with a
predisposition to develop the epileptic phenotype (DiFrancesco
and DiFrancesco, 2015).
Even if our analysis of the patients did not reveal, other than
the R550C mutation, significant variants in any of the epilepsy-
related genes screened, we cannot exclude further contribution
of mutations in other genes either unrelated or rarely associated
with epilepsy. Furthermore, we cannot rule out the presence
of mutations in the large portion of the non-coding genome
(e.g., long non-coding RNA, miRNA) which, influencing gene
expression, can potentially contribute to the penetrance of a
disease (Crino, 2007; Shao and Chen, 2017).
Within the general population, the HCN4 R550C variant is
rare, with a calculated frequency of 8.122e-66. The HCN4 variant
we found is characterized by a point mutation in the B’ helix of
the channel C-linker, whereby a positively charged arginine is
replaced by the polar amino acid cysteine. A positively charged
residue (arginine or lysine) is highly conserved in the same
position in all HCN isoforms and across species, suggesting a
highly relevant functional role.
Interestingly, it has been previously reported that the
corresponding residue of Arg-550 in the HCN2 isoform (Lys-
472) is one of the three fundamental residues generating salt
bridges, responsible for both inter- and intra-subunit interaction
in the tetrameric structure of the channel. Replacement of any
of these charged residues with residues bearing a charge of
opposite sign cause alterations of the channel kinetics (Craven
and Zagotta, 2004), thus confirming the importance of the
conserved positive charge in this position. Our data show that
the R550C mutation alters the channel kinetics by causing a
shift of the activation curve voltage dependence to more negative
voltages, thus reducing the channel contribution to keep a low
input resistance.
The genetic causes of benignmyoclonic epilepsy of infancy are
known only in a small proportion of patients. Most mutations
reported so far involve KCNQ2/3 (Castaldo et al., 2002) and
SCN1A genes (Gambardella and Marini, 2009), although in
the majority of cases, functional studies supporting evidence of
causative links are lacking.
The patients carrying the HCN4 R550C mutation described
here are affected by a mild form of infantile generalized epilepsy,
with good response to pharmacological treatment, benign
evolution and absence of sequelae in adulthood. This phenotype
is clearly milder than the pharmacoresistant generalized epilepsy
6http://gnomad.broadinstitute.org/
with tonic-clonic seizures with autosomal recessive inheritance
associated with the HCN2 mutation (E515K) we previously
reported (DiFrancesco et al., 2011). In the case of the
HCN2 mutation, a serious phenotype was associated with a
nearly complete loss-of-function of the channel contribution to
activity. In the present work, on the other hand, we have found
a less dramatic loss-of-function change of HCN4 contribution,
in association with an epileptic phenotype which is milder and
restricted to infancy.
The data we show in Figure 5, although in non-physiological
conditions, represent the first experimental evidence that
dysfunctional HCN4 channels can induce change in neuronal
excitability.
HCN4 channels are widely expressed in the CNS, where
they are mainly concentrated in the thalamus, especially in the
relay nuclei, habenular complex and basal ganglia (Moosmang
et al., 1999; Santoro et al., 2000; Notomi and Shigemoto,
2004; He et al., 2014). HCN4 channels have been most
thoroughly characterized for their role in cardiac pacemaking
(Baruscotti et al., 2011; DiFrancesco and Noble, 2012) and
several mutations have been associated with alterations of
cardiac rhythm (Milanesi et al., 2006; DiFrancesco, 2013;
Baruscotti et al., 2017). Full understanding of the specific
functions of HCN4 in neurons is however still lacking, and
the impact of dysfunctional mutant channels has yet to be
determined.
Nonetheless there are several indications that HCN4 channels
have a role in neuronal excitability. For example, an association
between HCN4 expression and high-frequency action potential
discharge has been reported in rat hippocampal interneurons
(Hughes et al., 2013).
Importantly, HCN4 expression in cortical regions is high at
early stages of life and declines rapidly at later stages, suggesting a
potential role of HCN4 dysfunctional behavior more specifically
in infantile forms of epilepsy.
Studies focusing on the role of HCN channel during brain
development have shown that HCN4 is highly expressed in
hippocampal CA1 neurons during the first postnatal period
(accounting for 30%–40% of the Ih current), whereas its
expression strongly decreases in adulthood (contributing only for
the 4%–8% of the total current).
Age-dependent adaptation of HCN4 expression is also
suggested by the fact that during brain development the Ih
properties change in ways compatible with HCN4 reduced
expression: the Ih current becomes less sensitive to cAMP,
acquires a faster activation time constant and its activation range
shifts to more negative voltages, as expected with a decreased
HCN4 contribution (Surges et al., 2006; Brewster et al., 2007).
Similar results on HCN4 expression during development
were obtained in different mouse hippocampal regions (Seo
et al., 2015). In thalamocortical neurons, too, HCN4 expression
contributes to the Ih current at early postnatal stages, while
at later stages the expression of HCN1 and HCN2 isoforms
becomes prominent (Kanyshkova et al., 2009). More recently,
a high perinatal expression of HCN4 and its strong decrease
later in life were reported in the developing neocortex (Battefeld
et al., 2012). Changes in developmental expression of various
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HCN subunits, and in particular of HCN4 and HCN1, is further
supported by the compensation through HCN4 upregulation
observed in the neocortex of HCN1 knockout mice (Stoenica
et al., 2013).
The above evidence suggests that most of the neuronal
phenotypic effects of HCN4 alterations may be restricted within
a limited period of time, pointing to a possible transient effect
of altered HCN4 on CNS function. We can thus speculate
that the HCN4 R550C mutation affects neuronal excitability
only in the early years of life, while the WT HCN1 and/or
HCN2 isoforms can subsequently compensate to re-establish
normal physiological conditions. This hypothesis is in agreement
with the phenotype of the patients described here, who presented
epileptic seizures only for the first 2 12 years of life.
On the other hand, the contribution of HCN4 is fundamental
for maintaining normal heart rhythm also in adulthood,
and since HCN channel properties are known to vary in
different cell types (Qu et al., 2002), we sought to verify
whether the R550C mutation might also have an effect
when expressed in cardiac myocytes. Our results in rat
neonatal cardiomyocytes show that the mutation produces
a modest negative shift in the activation curve of the
channel (Figure 6B). While our patients (individuals 3 and
4 in Figure 1A) did not present a symptomatic, overt
cardiac phenotype, their resting heart rate was in both cases
59 bpm, a value which can be considered as borderline
bradycardia, and their father had an only slightly higher
rate of 62 bpm. These data are coherent with the known
correlation between HCN4 loss-of-function mutations and
bradycardia (DiFrancesco, 2013, 2015; Verkerk and Wilders,
2015).
It is however important to note that, to our knowledge,
none of the patients already described with cardiac arrhythmias
due to HCN4 mutations has been reported to also present an
epileptic phenotype, suggesting that the HCN4 R550C mutation
reported here is likely to be a contributing factor requiring other
mechanisms or a still unidentified genetic background to express
an epileptic phenotype.
CONCLUSIONS
While HCN4 channelopathies have been mostly associated so
far with a variety of different types of inheritable cardiac
arrhythmias, the data presented here show that dysfunctional
HCN4 channels can also be involved in human epileptogenesis,
demonstrating for the first time that a loss-of-function
HCN4 mutation can lead to increased neuronal excitability.
While failure to detect in our patients other mutations
in almost 100 genes previously associated with epilepsy
pathogenesis and/or HCN channel function strengthens the
hypothesis of the involvement of the R550C HCN4 mutation in
the disease, it is important to stress that our data are not sufficient
to prove a causative role. We can however hypothesize that this
mutation acts as a predisposing factor, in the background of
other still undetermined contributing epigenetic and/or genetic
conditions.
Since HCN4 expression is high during infancy and declines
with age, our data support the intriguing possibility that this
HCN isoform has a more specific role in infantile forms of
epilepsy. Knowledge of genetic predisposition to myoclonic
epilepsy of infancy would be useful in the clinical setting
to facilitate early diagnosis and provide a simple and safe
tool for prompt therapeutic approach. In order to broaden
the analysis of potential pathogenic mechanisms and novel
pharmacological targets, it would be important to include HCN4
in the screening of the genetic factors contributing to infantile
epilepsies.
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